Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells

Blood

Volumn 113, Issue 22, 2009, Pages 5506-5515

  Kohlhof, Hella ^a   Hampel, Franziska ^a   Hoffmann, Reinhard ^b   Burtscher, Helmut ^c   Weidle, Ulrich H ^c   Hölzel, Michael ^d   Eick, Dirk ^a   Zimber Strobl, Ursula ^a   Strobl, Lothar J ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOXYCYCLINE; EPSTEIN BARR VIRUS ANTIGEN 2; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; RNA; EBNA 2 PROTEIN, HUMAN HERPESVIRUS 4; EBNA-2 PROTEIN, HUMAN HERPESVIRUS 4; EPSTEIN BARR VIRUS ANTIGEN; NOTCH1 PROTEIN, HUMAN; NOTCH2 PROTEIN, HUMAN; RECOMBINANT PROTEIN; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL CYCLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENOME; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; BIOLOGICAL MODEL; CELL CULTURE; CELL CYCLE S PHASE; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

APOPTOSIS; B-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; HUMANS; LYMPHOMA, B-CELL; MODELS, BIOLOGICAL; RECEPTOR, NOTCH1; RECEPTOR, NOTCH2; RECOMBINANT PROTEINS; S PHASE; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 67049097357     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-11-190090     Document Type: Article

References (49)

1. Blaumueller CM, Qi H, Zagouras P, Artavanis- Tsakonas S. Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell. 1997;90:281-291. (Pubitemid 27329713)
2. Zimber-Strobl U, Strobl LJ. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol. 2001;11:423-434. (Pubitemid 33105021)
3. Radtke F, Wilson A, Stark G, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 1999;10:547-558. (Pubitemid 29262657)
4. Saito T, Chiba S, Ichikawa M, et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity. 2003;18:675-685. (Pubitemid 36588584)
5. Ellisen LW, Bird J, West DC, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66:649-661. (Pubitemid 121001701)
6. Henkel T, Ling PD, Hayward SD, Peterson MG. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jkappa. Science. 1994;265:92-95. (Pubitemid 24985550)
7. Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the Jkappa recombination signal binding protein. Proc Natl Acad Sci U S A. 1994;91:7568-7572. (Pubitemid 24238226)
8. Zimber-Strobl U, Strobl LJ, Meitinger C, et al. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBPJkappa, the homologue of Drosophila suppressor of hairless. EMBO J. 1994;13:4973-4982. (Pubitemid 24319380)
9. Ghosh D, Kieff E. cis-Acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site. J Virol. 1990;64:1855-1858.
10. Zimber-Strobl U, Suentzenich KO, Laux G, et al. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J Virol. 1991;65:415-423.
11. Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol. 2001; 1:75-82.
12. Hömig-Hölzel C, Hojer C, Rastelli J, et al. Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis. J Exp Med. 2008; 205:1317-1329. (Pubitemid 351831489)
13. Rastelli J, Hömig-Hölzel C, Seagal J, et al. LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing classswitch recombination to IgG1. Blood. 2008;111: 1448-1455. (Pubitemid 351213432)
14. 1- regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J. 1995;14:88-96.
15. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 1994;13:3321-3328.
16. Kaiser C, Laux G, Eick D, Jochner N, Bornkamm GW, Kempkes B. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J Virol. 1999;73:4481-4484. (Pubitemid 29189900)
17. Spender LC, Cornish GH, Sullivan A, Farrell PJ. Expression of transcription factor AML-2 (RUNX3, CBFalpha-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J Virol. 2002;76:4919-4927. (Pubitemid 34441698)
18. Schlee M, Krug T, Gires O, et al. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV. J Virol. 2004;78:3941-3952. (Pubitemid 38437200)
19. Burgstahler R, Kempkes B, Steube K, Lipp M. Expression of the chemokine receptor BLR2/ EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2. Biochem Biophys Res Commun. 1995;215:737-743.
20. Maier S, Staffler G, Hartmann A, et al. Cellular target genes of Epstein-Barr virus nuclear antigen 2. J Virol. 2006;80:9761-9771. (Pubitemid 44435650)
21. Höfelmayr H, Strobl LJ, Marschall G, Bornkamm GW, Zimber-Strobl U. Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells. J Virol. 2001;75:2033-2040. (Pubitemid 32147542)
22. Gordadze AV, Peng R, Tan J, et al. Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus. J Virol. 2001;75: 5899-5912. (Pubitemid 32553120)
23. Bornkamm GW, Berens C, Kuklik-Roos C, et al. Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res. 2005;33:e137. (Pubitemid 41508686)
24. Fruehling S, Swart R, Dolwick KM, Kremmer E, Longnecker R. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J Virol. 1998;72:7796-7806. (Pubitemid 28421769)
25. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98:5116-5121. (Pubitemid 32397092)
26. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
27. Strobl LJ, Höfelmayr H, Marschall G, Brielmeier M, Bornkamm GW, Zimber-Strobl U. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J Virol. 2000;74:1727-1735. (Pubitemid 30434029)
28. Dirmeier U, Hoffmann R, Kilger E, et al. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene. 2005;24:1711-1717. (Pubitemid 40461127)
29. Vockerodt M, Morgan SL, Kuo M, et al. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype. J Pathol. 2008;216:83-92.
30. Kilpinen S, Autio R, Ojala K, et al. Systematic bioinformatic analysis of expression levels of 17 330 human genes across 9783 samples from 175 types of healthy and pathologic tissues. Genome Biol. 2008;9:R139.
31. Laux G, Adam B, Strobl LJ, Moreau-Gachelin F. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-Jkappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. EMBO J. 1994;13:5624-5632. (Pubitemid 24363030)
32. Cannell EJ, Farrell PJ, Sinclair AJ. Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalization of primary B-cells. Oncogene. 1996;13:1413-1421.
33. Ronchini C, Capobianco AJ. Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol. 2001;21:5925-5934. (Pubitemid 32737809)
34. Stahl M, Ge C, Shi S, Pestell RG, Stanley P. Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin D1. Cancer Res. 2006;66:7562-7570. (Pubitemid 44289212)
35. Kilger E, Kieser A, Baumann M, Hammerschmidt W. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 1998;17:1700-1709. (Pubitemid 28119123)
36. Weng AP, Millholland JM, Yashiro-Ohtani Y, et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 2006;20:2096-2109. (Pubitemid 44157460)
37. Palomero T, Lim WK, Odom DT, et al. NOTCH1 directly regulates c-MYC and activates a feedforward- loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A. 2006;103:18261-18266. (Pubitemid 44871646)
38. Sharma VM, Calvo JA, Draheim KM, et al. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol. 2006;26:8022-8031.
39. Schuhmacher M, Staege MS, Pajic A, et al. Control of cell growth by c-Myc in the absence of cell division. Curr Biol. 1999;9:1255-1258. (Pubitemid 29527152)
40. Hubmann R, Schwarzmeier JD, Shehata M, et al. Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia. Blood. 2002;99:3742-3747. (Pubitemid 34534546)
41. Jundt F, Probsting KS, Anagnostopoulos I, et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood. 2004;103: 3511-3515. (Pubitemid 38525685)
42. Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 2002;99:3398-3403. (Pubitemid 34525322)
43. Zweidler-McKay PA, He Y, Xu L, et al. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood. 2005;106:3898-3906. (Pubitemid 41739030)
44. Morimura T, Goitsuka R, Zhang Y, Saito I, Reth M, Kitamura D. Cell cycle arrest and apoptosis induced by Notch1 in B cells. J Biol Chem. 2000; 275:36523-36531. (Pubitemid 32002049)
45. Romer S, Saunders U, Jack HM, Jehn BM. Notch1 enhances B-cell receptor-induced apoptosis in mature activated B cells without affecting cell cycle progression and surface IgM expression. Cell Death Differ. 2003;10:833-844. (Pubitemid 36850244)
46. Thomas M, Calamito M, Srivastava B, Maillard I, Pear WS, Allman D. Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation. Blood. 2007;109:3342-3350. (Pubitemid 46572522)
47. Gupta-Rossi N, Storck S, Griebel PJ, Reynaud CA, Weill JC, Dahan A. Specific over-expression of deltex and a new Kelch-like protein in human germinal center B cells. Mol Immunol. 2003;39: 791-799. (Pubitemid 36263130)
48. Maillard I, Weng AP, Carpenter AC, et al. Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood. 2004;104:1696-1702. (Pubitemid 39202276)
49. Kogoshi H, Sato T, Koyama T, Nara N, Tohda S. gamma-Secretase inhibitors suppress the growth of leukemia and lymphoma cells. Oncol Rep. 2007;18:77-80.